Abstract
Whilst many studies have examined the role of the MAP Kinases in regulating the G1→S transition, much less is known about the function of these pathways in regulating other cell cycle transitions. Stimulation of the conditional mutant ΔMEKK3:ER* in asynchronous hamster (CCl39) and rat (Rat-1) fibroblasts resulted in the strong activation of endogenous JNK and p38 but only a weak activation of ERK. Activation of ΔMEKK3:ER* inhibited cell proliferation through a combination of an initial G1 and G2 cell cycle arrest, followed by a delayed onset of apoptosis. When cells were synchronized in S phase with aphidicolin and then released, activation of ΔMEKK3:ER* resulted in the up-regulation of p21CIP1 and a pronounced inhibition of cyclin A/CDK2 and cyclin B1/CDK1 kinase activity. Analysis of mitotic figures indicated that cells failed to enter mitosis, arresting late in G2. ΔMEKK3:ER*-mediated CDK inhibition and G2 arrest did not absolutely require p21CIP1, since both events were observed in Rat-1 cells in which p21CIP1 is transcriptionally silenced due to promoter methylation. Rather, CDK inhibition was associated with a down-regulation of cyclin A and B1 expression. Finally, application of the p38 inhibitor SB203580 partially restored cyclin B associated kinase activity and allowed cells to proceed through mitosis into the next G1 phase, suggesting that activation of the p38α/β2 pathway can promote a G2 cell cycle arrest.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alexander MR, Tyers M, Perret M, Craig BM, Fang KM, Gustin MC . 2001 Mol. Biol. Cell 12: 53–62
Allan LA, Duhig T, Read M, Fried M . 2000 Mol. Cell. Biol. 20: 1291–1298
Balmanno K, Cook SJ . 1999 Oncogene 18: 3085–3097
Bates S, Ryan KM, Phillips AC, Vousden KH . 1998 Oncogene 17: 1691–1703
Blasina A, Paegle ES, McGowan CH . 1997 Mol. Biol. Cell 8: 1013–1023
Booher RN, Holman PS, Fattaey A . 1997 J. Biol. Chem. 272: 22300–22306
Brown AL, Lee CH, Schwarz JK, Mitiku N, Piwnica-Worms H, Chung JH . 1999 Proc. Natl. Acad. Sci. USA 96: 3745–3750
Brugarolas J, Chandrasekaran C, Gordon JC, Beach D, Jacks T, Hannon GJ . 1995 Nature 377: 552–556
Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, Sedivy JM, Kinzler KW, Vogelstein B . 1998 Science 282: 1497–1501
Clarke DJ, Giménez-Abián JF . 2000 BioEssays 22: 351–363
Cook SJ, Balmanno K, Garner A, Millar T, Taverner C, Todd D . 2000 Biochem. Soc. Trans. 28: 233–240
Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC . 1995 FEBS Lett. 364: 229–233
Davis RJ . 2000 Cell 103: 239–252
Deacon K, Blank JL . 1997 J. Biol. Chem. 272: 14489–14496
Deacon K, Blank JL . 1999 J. Biol. Chem. 274: 16604–16610
Dawson I, Roth AS, Artavanis-Tsakonas S . 1995 J. Cell Biol. 129: 725–737
Deng C, Zhang P, Harper JW, Elledge SJ, Leder P . 1995 Cell 82: 675–684
Dulic V, Stein GH, Far DF, Reed SI . 1998 Mol. Cell. Biol. 546: 546–557
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell 75: 817–825
Elledge SJ . 1996 Science 274: 1664–1672
Ellinger-Ziegelbauer H, Kelly K, Siebenlist U . 1999 Mol. Cell. Biol. 19: 3857–3868
Enslen H, Raingeaud J, Davis RJ . 1998 J. Biol. Chem. 273: 1741–1748
Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM . 1998 J. Biol. Chem. 273: 18623–18632
Fesquet D, Labbe JC, Derancourt J, Capony JP, Galas S, Girard F, Lorca T, Shuttleworth J, Doree M, Cavadore JC . 1993 EMBO J. 12: 3111–3121
Furono N, den Elzen N, Pines J . 1999 J. Cell Biol. 147: 295–306
Girard F, Strausfeld U, Fernandez U, Lamb NJ . 1991 Cell 67: 1169–1179
Glotzer M, Murray AW, Kirschner MW . 1991 Nature 349: 132–138
Gould KL, Nurse P . 1989 Nature 342: 39–42
Gu Y, Turck CW, Morgan DO . 1993 Nature 366: 707–710
Guardagno TM, Newport JW . 1996 Cell 84: 73–82
Guo N, Faller DV, Vazir C . 2000 J. Biol. Chem. 275: 1715–1722
Haccard O, Sarcevic B, Lewellyn A, Hartley R, Roy L, Izumi T, Erikson E, Maller JL . 1993 Science 262: 1262–1265
Hagting A, Jackman M, Simpson K, Pines J . 1999 Curr. Biol. 9: 680–689
Hall M, Peters G . 1996 Adv. Cancer Res. 68: 67–108
Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connel-Crowley CL, Swindell E, Fox MP, Wei N . 1995 Mol. Biol. Cell 6: 387–400
Harper J, Adami WGR, Wei N, Keyomarsi K, Elledge SJ . 1993 Cell 75: 805–816
Hiebert SW, Chellappan SP, Horowitz JM, Nevins JR . 1992 Genes Dev. 6: 177–185
Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC . 1994 Nuc. Acids Res. 22: 3551–3555
Innocente SA, Abrahamson JLA, Cogswell JP, Lee JM . 1999 Proc. Natl. Acad. Sci. USA 96: 2147–2152
Jin P, Gu Y, Morgan DO . 1996 J. Cell Biol. 134: 963–970
Kardassis D, Papakosta P, Pardali K, Moustakas A . 1999 J. Biol. Chem. 274: 29572–29581
King RW, Deshaies RJ, Peters RM, Kirschner MW . 1996 Science 274: 1652–1659
Knudsen ES, Wang JYJ . 1997 Mol. Cell. Biol. 17: 5771–5783
Kosako H, Gotoh Y, Nishida E . 1994 EMBO J. 13: 2131–2138
Kotani S, Tanaka H, Yasuda H, Todokoro K . 1999 J. Cell Biol. 146: 791–800
Labbe JC, Capony JP, Caput D, Cavadore JC, Derancourt J, Kaghad M, Lelias JM, Picard A, Doree M . 1989 EMBO J. 8: 3053–3058
Le-Niculescu H, Bonfoco E, Kasuya Y, Claret FX, Green DR, Karin M . 1999 Mol. Cell. Biol. 19: 751–763
Li J, Meyer AN, Donoghue DJ . 1995 Mol. Biol. Cell 6: 1111–1124
Li Y, Jenkins CW, Nichols MA, Xiong Y . 1994 Oncogene 9: 2261–2268
Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ . 2000 Genes Dev. 14: 1448–1459
Lopez-Girona A, Furnari B, Mondesert O, Russell P . 1999 Nature 397: 172–175
Lukas C, Storgaard Sørensen C, Kramer E, Santoni-Rugiu E, Lindeneg J, Peters J-M, Bartek J, Lukas J . 1999 Nature 401: 815–818
Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T . 1995 Genes Dev. 9: 935–944
Maity A, McKenna WG, Muschel RJ . 1995 EMBO J. 14: 603–609
Matsuoka S, Huang M, Elledge SJ . 1998 Science 282: 1893–1897
Medama RH, Klompmaker R, Smits VAJ, Rijsken G . 1998 Oncogene 16: 431–441
Meijer J, Azzi L, Wang JY . 1991 EMBO J. 10: 1545–1554
Mueller PR, Coleman TR, Kumagai A, Dunphy WG . 1995 Science 270: 86–90
Muschel RJ, Zhang HB, Iliakis G, McKenna WG . 1991 Cancer Res. 51: 5113–5117
Nebreda AR, Porras A . 2000 Trends Biochem. Sci. 25: 257–260
Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M . 1995 Mol. Cell. Biol. 15: 2612–2624
Passlaris TM, Benanti JA, Gewin L, Kiyono T, Galloway DA . 1999 Mol. Cell. Biol. 19: 5872–5881
Parker LL, Sylvestre PJ, Byrnes MJ, Liu F, Piwnica-Worms H . 1995 Proc. Natl. Acad. Sci. USA 92: 9638–9642
Peterson BO, Lukas J, Storgaard Sørensen C, Bartek J, Helin K . 1999 EMBO J. 18: 396–410
Petrocelli T, Singerland J . 2000 Oncogene 19: 4480–4490
Pines J, Hunter T . 1989 Cell 58: 833–846
Piwnica-Worms H . 1999 Nature 401: 535–537
Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massagué J . 1994 Cell 78: 59–66
Poon RYC, Jiang W, Toyoshima H, Hunter T . 1996 J. Biol. Chem. 271: 13283–13291
Russell P, Nurse P . 1987 Cell 49: 559–567
Samuels ML, Weber MJ, Bishop JM, McMahon M . 1993 Mol. Cell. Biol. 13: 6241–6252
Scolnick DM, Halazonetis TD . 2000 Nature 406: 430–435
Sherr CJ . 1996 Science 274: 1672–1677
Sherr CJ, Roberts JM . 1995 Genes Dev. 9: 1149–1163
Sigrist S, Jacobs H, Stratmann R, Lehner CF . 1995 EMBO J. 14: 4827–4838
Smith JL, Schaffner AE, Hofmeister JK, Hartman M, Wei G, Forsthoefel D, Hume DA, Ostrowski MC . 2000 Mol. Cell. Biol. 20: 8026–8034
Solomon MJ, Lee T, Kirschner MW . 1992 Mol. Biol. Cell 3: 13–27
Spitkovsky D, Schulze A, Boye B, Jansen-Durr P . 1997 Cell Growth Differ. 8: 699–710
Sudakin V, Ganoth D, Dahan A, Heller H, Hershko J, Luca FC, Ruderman JV, Hershko A . 1995 Mol. Biol. Cell 6: 185–198
Takenaka K, Moriguchi T, Nishida E . 1998 Science 280: 599–602
Toyoshima H, Hunter T . 1994 Cell 78: 67–74
Waldmann T, Kinzler KW, Vogelstein B . 1995 Cancer Res. 55: 5187–5190
Wang S, Nath N, Minden A, Chellappan S . 1999 EMBO J. 18: 1559–1570
Wang W, Caldwell MC, Lin S, Furneaux H, Gorospe M . 2000a EMBO J. 19: 2340–2350
Wang X, McGowan CH, Zhao M, He L, Downey JS, Fearns C, Wang Y, Huang S, Han J . 2000b Mol. Cell. Biol. 20: 4543–4552
Whitmarsh AJ, Yang SH, Su MS-S, Sharrocks AD, Davis RJ . 1997 Mol. Cell. Biol. 17: 2360–2371
Wisdom R, Johnson RS, Moore C . 1999 EMBO J. 18: 188–197
Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M . 1997 Mol. Cell. Biol. 17: 5598–5611
Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D . 1993 Nature 366: 701–704
Yang J, Winkler K, Yoshida M, Kornbluth S . 1999 EMBO J. 18: 2174–2183
Yang J, Boerm M, McCarty M, Bucana C, Fidler IJ, Zhuang Y, Su B . 2000 Nat. Genet. 24: 309–313
Acknowledgements
We would like to thank Geoff Morgan for maintenance of the Babraham Institute Flow Cytometry Facility and for his technical advice, Adele Murrell for advice on counting mitotic indices and members of the Cook group for interesting discussions and comments. We are grateful to Tim Hunt for the generous provision of cyclin A and B antibodies, Jiri Lukas for Cdh1 antibodies, James Trzaskos (DuPont) for providing U0126 and Bert Vogelstein for providing WT and p53−/− HCT116 cells. This work was supported by Cancer Research UK (SP2458/0201), the BBSRC Science of Ageing Initiative (202/SAG10012) and a Competitive Strategic Grant from the BBSRC. CR Weston was funded by a MRC PhD studentship and SJ Cook is a Senior Cancer Research Fellow of Cancer Research UK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Garner, A., Weston, C., Todd, D. et al. ΔMEKK3:ER* activation induces a p38α/β2-dependent cell cycle arrest at the G2 checkpoint. Oncogene 21, 8089–8104 (2002). https://doi.org/10.1038/sj.onc.1206000
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206000
Keywords
This article is cited by
-
Phosphorylation of HtrA2 by cyclin-dependent kinase-5 is important for mitochondrial function
Cell Death & Differentiation (2012)
-
The mitochondrial protease HtrA2 is regulated by Parkinson's disease-associated kinase PINK1
Nature Cell Biology (2007)
-
Bendamustine induces G2 cell cycle arrest and apoptosis in myeloma cells: the role of ATM-Chk2-Cdc25A and ATM-p53-p21-pathways
Journal of Cancer Research and Clinical Oncology (2007)
-
cGMP-independent nitric oxide signaling and regulation of the cell cycle
BMC Genomics (2005)
-
ERK1/2 and p38 cooperate to induce a p21CIP1-dependent G1 cell cycle arrest
Oncogene (2004)